Form 4 for ARTV Artiva Biotherapeutics, Inc.
Accepted 2025-02-28 00:00:00 ET · period of report 2025-02-26 · accession 0001415889-25-006036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-28 | 2025-02-26 | ARTV | Graef Thorsten | Chief Medical Off | A - Grant | $0.00 | +60.0K | 80.0K | +300% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-26 | A | A | 60,000 | $0.00 | 80,000 | D | — | — | (F1) Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan. |